Crossref
Efficacy and safety of semaglutide 7.2 mg in obesity: STEP UP trial
Obesity Abstracts · 28.11.2025
DOI: 10.1530/obabs.05.p3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Abstracts, online erschienen am 28.11.2025. Verfasst von Iskandar Idris und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Idris, I., Wharton, S., Freitas, P., Hjelmesaeth, J., Kabisch, M., Kandler, K., Lingvay, I., De, L. A. Q. P. M., Rosenstock, J., & Garvey, W. T. (2025). Efficacy and safety of semaglutide 7.2 mg in obesity: STEP UP trial. Obesity Abstracts. https://doi.org/10.1530/obabs.05.p3
Vancouver
Idris I, Wharton S, Freitas P, Hjelmesaeth J, Kabisch M, Kandler K, et al. Efficacy and safety of semaglutide 7.2 mg in obesity: STEP UP trial. Obesity Abstracts. 2025. doi:10.1530/obabs.05.p3
BibTeX
@article{Idris2025,
author = {Idris, Iskandar and Wharton, Sean and Freitas, Paula and Hjelmesaeth, Joran and Kabisch, Maria and Kandler, Kristian and Lingvay, Ildiko and De, Los Angeles Quiroga Pelaez Maria and Rosenstock, Julio and Garvey, W. Timothy},
title = {Efficacy and safety of semaglutide 7.2 mg in obesity: STEP UP trial},
journal = {Obesity Abstracts},
year = {2025},
doi = {10.1530/obabs.05.p3}
}
EUVIMED